查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600975

吸入一氧化氮市場：按應用程式、最終用戶分類 - 2025-2030 年全球預測

Inhaled Nitric Oxide Market by Application (Acute Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease, Malaria Treatment), End-Users (Clinic, Hospital) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年吸入一氧化氮市場價值為7.7821億美元，預計到2024年將達到8.2109億美元，複合年成長率為5.83%，預計到2030年將達到11.5738億美元。

吸入一氧化氮 (iNO) 是一種重要的治療藥物，用於治療呼吸衰竭和肺動脈高壓，主要用於新生兒和成人患者。 iNO 市場範圍涵蓋醫療保健環境中的各種應用，包括醫院和專科診所。 iNO 廣泛用於新生兒肺血管舒張的治療和某些心血管手術，擴大了最終用途的範圍。市場成長受到輸送系統技術進步的強烈影響，例如改善患者治療效果和依從性的攜帶式設備。對非侵入性和微創治療方案不斷成長的需求進一步增強了市場潛力。最新的機會存在於新興市場和開拓的人口統計中，需要策略性擴張和研發投資，以探索新的治療適應症和配方。此外，與醫療機構的合作可以有助於採用和創新。然而，嚴格的監管要求以及與 iNO 療法的開發和實施相關的高成本對市場成長構成了挑戰。此外，來自替代療法和非專利藥的競爭可能會阻礙進展。儘管有這些限制，iNO 的創新途徑包括改善遞送機制、提高效率和擴大治療適應症。將 iNO 與其他療法結合以產生協同效應的研究也提供了另一種生長載體。市場的特徵是競爭激烈、技術創新迅速。想要取得成功的公司應該專注於提高 iNO 治療的有效性和安全性、簡化監管核准以及擴大其地理和人口覆蓋範圍。透過解決這些方面，公司可以有效地佔領並擴大其在不斷成長的市場格局中的佔有率。

主要市場統計
基準年[2023] 77821萬美元
預測年份 [2024] 82109萬美元
預測年份 [2030] 115,738 萬美元
複合年成長率（%） 5.83%

市場動態：快速發展的吸入一氧化氮市場的關鍵市場洞察

供需的動態交互作用正在改變吸入一氧化氮市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球呼吸系統疾病增加
    • 隨著醫療保健支出的增加，新生兒加護治療設施也隨之增加
  • 市場限制因素
    • 吸入一氧化氮的治療高成本
  • 市場機會
    • 改進吸入一氧化氮的生產和儲存技術
    • 正在進行的研究以推進吸入一氧化氮的應用
  • 市場挑戰
    • 政府對吸入一氧化氮的使用有嚴格的規定

波特五力：駕馭吸入一氧化氮市場的策略工具

波特的五力框架是了解吸入一氧化氮市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解吸入一氧化氮市場的外部影響

外部宏觀環境因素在塑造吸入一氧化氮市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解吸入一氧化氮市場的競爭狀況

吸入一氧化氮市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣吸入一氧化氮市場供應商績效評估

FPNV 定位矩陣是評估吸入一氧化氮市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地呼吸系統疾病的發生率增加
      • 隨著醫療費用的增加，新生兒加護治療設施的增加
    • 抑制因素
      • 與吸入一氧化氮相關的治療費用昂貴
    • 機會
      • 改進吸入一氧化氮的生產和儲存技術
      • 持續研究推進吸入一氧化氮的應用
    • 任務
      • 關於吸入一氧化氮使用的嚴格政府法規
  • 市場區隔分析
    • 應用：慢性阻塞性肺病的發生率增加
    • 最終用戶：醫院新生兒和加加護病房擴大採用吸入一氧化氮裝置
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章吸入一氧化氮市場：依應用分類

  • 急性呼吸頻率綜合症
  • 慢性阻塞性肺病
  • 瘧疾治療
  • 新生兒呼吸治療
  • 結核病治療

第7章 吸入一氧化氮市場：依最終使用者分類

  • 診所
  • 醫院

第8章美洲吸入一氧化氮市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太吸入一氧化氮市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲吸入一氧化氮市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Vero Biotech 獲得 6,500 萬美元的一氧化氮輸送系統信貸額度
    • ThirdPol 對一氧化氮輸送系統試驗中的第一位患者進行了注射
    • Mallinckrodt 宣布 FDA 批准 INOmax EVOLVE DS 輸送系統和 INOmax（一氧化氮）核准氣瓶
    • 阿拉巴馬大學研究人員接受津貼開發可以改善肺動脈高壓患者生活品質的設備
    • Beyond Air 獲得高達 4,000 萬美元的債務融資
    • VERO Biotech 融資 3000 萬美元，加速創新無槽輸送系統的商業化
    • VERO Biotech 的第三代無罐吸入一氧化氮輸送系統獲得 FDA核准
    • SaNOtize 宣布獲得 2,400 萬美元 B 輪資金籌措，以推進一氧化氮治療藥物的開發，包括鼻噴劑，用於治療和預防 COVID-19

公司名單

  • Air Liquide SA
  • Beyond Air, Inc.
  • GE HealthCare Technologies, Inc.
  • Getinge AB
  • Linde PLC
  • Mallinckrodt PLC
  • Matheson Tri-Gas, Inc. by Mitsubishi Chemical Group Corporation
  • Merck KGaA
  • NIOX Group PLC
  • Perma Pure LLC by Halma PLC
  • SOL Group
  • Third Pole, Inc.
  • VERO Biotech Inc.
Product Code: MRR-2D668742FD36

The Inhaled Nitric Oxide Market was valued at USD 778.21 million in 2023, expected to reach USD 821.09 million in 2024, and is projected to grow at a CAGR of 5.83%, to USD 1,157.38 million by 2030.

Inhaled Nitric Oxide (iNO) serves as a critical therapeutic agent primarily used for the treatment of respiratory failure and pulmonary hypertension in neonatal and adult patients. The scope of the iNO market encompasses a range of applications in healthcare settings, including hospitals and specialized clinics. The increasing incidence of chronic respiratory diseases and a growing preterm birth rate significantly drive the necessity for this therapeutic gas. iNO is extensively used to manage pulmonary vasodilation in neonates and certain cardiac surgeries, expanding its end-use scope. Market growth is strongly influenced by technological advancements in delivery systems, such as portable devices, which improve patient outcomes and compliance. The rising demand for non-invasive and minimally invasive therapeutic options further reinforces its market potential. Latest opportunities lie in emerging markets and untapped demographics, necessitating strategic expansion and investment in R&D to explore novel therapeutic indications and formulations. Additionally, partnerships with healthcare institutions can aid in widespread adoption and innovation. However, market growth faces challenges from stringent regulatory requirements and high costs associated with the development and delivery of iNO therapies. Furthermore, competition from alternative treatments and generic products can hinder advancements. Despite such limitations, innovation avenues in iNO include improving delivery mechanisms, increasing its efficiency, and expanding its therapeutic indications. Research into combining iNO with other therapeutic agents for synergistic effects offers another growth vector. The market is characterized by a blend of high competition and rapid innovation. Companies aiming for success should focus on enhancing the efficacy and safety of iNO treatments, streamline regulatory approvals, and expand their geographic and demographic reach. By addressing these aspects, businesses can effectively capture and expand their share in the growing inhaled nitric oxide market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 778.21 million
Estimated Year [2024] USD 821.09 million
Forecast Year [2030] USD 1,157.38 million
CAGR (%) 5.83%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Inhaled Nitric Oxide Market

The Inhaled Nitric Oxide Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidents of respiratory disorders worldwide
    • Increase in neonatal intensive care facilities with growing healthcare expenditure
  • Market Restraints
    • High cost associated with treatments involving inhaled nitric oxide
  • Market Opportunities
    • Improvements in production and storage technologies of inhaled nitric oxide
    • Continuous research to boost the application of inhaled nitric oxide
  • Market Challenges
    • Stringent government regulations for inhaled nitric oxide usage

Porter's Five Forces: A Strategic Tool for Navigating the Inhaled Nitric Oxide Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Inhaled Nitric Oxide Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Inhaled Nitric Oxide Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Inhaled Nitric Oxide Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Inhaled Nitric Oxide Market

A detailed market share analysis in the Inhaled Nitric Oxide Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Inhaled Nitric Oxide Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Inhaled Nitric Oxide Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Inhaled Nitric Oxide Market, highlighting leading vendors and their innovative profiles. These include Air Liquide SA, Beyond Air, Inc., GE HealthCare Technologies, Inc., Getinge AB, Linde PLC, Mallinckrodt PLC, Matheson Tri-Gas, Inc. by Mitsubishi Chemical Group Corporation, Merck KGaA, NIOX Group PLC, Perma Pure LLC by Halma PLC, SOL Group, Third Pole, Inc., and VERO Biotech Inc..

Market Segmentation & Coverage

This research report categorizes the Inhaled Nitric Oxide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Acute Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease, Malaria Treatment, Neonatal Respiratory Treatment, and Tuberculosis Treatment.
  • Based on End-Users, market is studied across Clinic and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidents of respiratory disorders worldwide
      • 5.1.1.2. Increase in neonatal intensive care facilities with growing healthcare expenditure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with treatments involving inhaled nitric oxide
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in production and storage technologies of inhaled nitric oxide
      • 5.1.3.2. Continuous research to boost the application of inhaled nitric oxide
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations for inhaled nitric oxide usage
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Application: Increasing incidences of chronic obstructive pulmonary disease
    • 5.2.2. End-Users: Growing deployment of inhaled nitric oxide devices in hospitals for neonatal and intensive care units
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Inhaled Nitric Oxide Market, by Application

  • 6.1. Introduction
  • 6.2. Acute Respiratory Distress Syndrome
  • 6.3. Chronic Obstructive Pulmonary Disease
  • 6.4. Malaria Treatment
  • 6.5. Neonatal Respiratory Treatment
  • 6.6. Tuberculosis Treatment

7. Inhaled Nitric Oxide Market, by End-Users

  • 7.1. Introduction
  • 7.2. Clinic
  • 7.3. Hospital

8. Americas Inhaled Nitric Oxide Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Inhaled Nitric Oxide Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Inhaled Nitric Oxide Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Vero Biotech Secures USD 65 Million Credit Facility for Nitric Oxide Delivery System
    • 11.3.2. Third Pole Doses First Patient in Trial with Nitric Oxide Delivery System
    • 11.3.3. Mallinckrodt Announces FDA Clearance of the INOmax EVOLVE DS Delivery System and Approval of the INOmax (Nitric Oxide) Mini-Cylinder
    • 11.3.4. UAB Researchers Receive Grant to Develop Devices That Can Improve Quality of Life for Patients with Pulmonary Hypertension
    • 11.3.5. Beyond Air Secures up to USD 40 Million Debt Financing
    • 11.3.6. VERO Biotech Raises USD 30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery System
    • 11.3.7. VERO Biotech Receives FDA Approval of its Third Generation Tankless Inhaled Nitric Oxide Delivery System
    • 11.3.8. SaNOtize Announces USD 24 Million in Series B Funding to Advance It's Nitric Oxide-Based Therapeutics, Including Nasal Spray for the Treatment and Prevention of COVID-19

Companies Mentioned

  • 1. Air Liquide SA
  • 2. Beyond Air, Inc.
  • 3. GE HealthCare Technologies, Inc.
  • 4. Getinge AB
  • 5. Linde PLC
  • 6. Mallinckrodt PLC
  • 7. Matheson Tri-Gas, Inc. by Mitsubishi Chemical Group Corporation
  • 8. Merck KGaA
  • 9. NIOX Group PLC
  • 10. Perma Pure LLC by Halma PLC
  • 11. SOL Group
  • 12. Third Pole, Inc.
  • 13. VERO Biotech Inc.

LIST OF FIGURES

  • FIGURE 1. INHALED NITRIC OXIDE MARKET RESEARCH PROCESS
  • FIGURE 2. INHALED NITRIC OXIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. INHALED NITRIC OXIDE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. INHALED NITRIC OXIDE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INHALED NITRIC OXIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INHALED NITRIC OXIDE MARKET DYNAMICS
  • TABLE 7. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY MALARIA TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL RESPIRATORY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY TUBERCULOSIS TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. INHALED NITRIC OXIDE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. INHALED NITRIC OXIDE MARKET, FPNV POSITIONING MATRIX, 2023